Grade II glioma
MONDO:0021639A glioma arising from the central nervous system. This category includes diffuse astrocytoma, ependymoma, oligodendroglioma, and oligoastrocytoma.
Also known as: WHO grade II glioma, grade II glioma
1617 clinical trials for this condition and its sub-types, 28 tagged with Grade II glioma itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Grade II glioma
-
Ependymoma 87 trials · 89 incl. sub-types
8 sub-types
- Childhood ependymoma 7 trials Sub-types →
- Cellular ependymoma 1 trial
- Clear cell ependymoma 1 trial
- Low grade ependymoma 0 trials · 1 incl. sub-types Sub-types →
- Papillary ependymoma 1 trial
- Brain stem ependymoma 0 trials
- Spinal cord ependymoma 0 trials Sub-types →
- Tanycytic ependymoma 0 trials
-
Oligodendroglioma 62 trials
4 sub-types
- Adult oligodendroglioma 3 trials
- Childhood oligodendroglioma 1 trial
- Brain oligodendroglioma 0 trials Sub-types →
- Spinal cord oligodendroglioma 0 trials
-
Diffuse astrocytoma 25 trials · 28 incl. sub-types
4 sub-types
- Fibrillary astrocytoma 3 trials
- Diffuse astrocytoma, MYB- or MYBL1-altered 0 trials
- Gemistocytic astrocytoma 0 trials
- Protoplasmic astrocytoma 0 trials
-
Oligoastrocytoma 6 trials · 15 incl. sub-types
1 sub-type
- Anaplastic oligoastrocytoma 12 trials
Most studied deeper sub-types
-
AI reads MRI scans to spot brain tumors without surgery
Diagnosis CompletedThis study tests whether an artificial intelligence system called GliomaAI-Astro23 can identify a specific type of brain tumor (IDH mutant astrocytoma) from routine MRI scans. Researchers are using existing MRI data from 1,372 patients to train and evaluate the AI. If accurate, t…
Sponsor: Deep Learning Institute of Radiological Sciences • Aim: Diagnosis
Last updated Jul 01, 2026 00:00 UTC
-
New dye could sharpen PET scans for recurrent brain cancer
Diagnosis CompletedThis study tested whether a special dye called fluoroethyltyrosine (FET) can improve PET scans for detecting brain tumors that have come back. 143 people with suspected recurrent brain tumors received an injection of FET before their PET scan. The goal was to see if FET-PET could…
Phase 2 • Sponsor: Thomas Hope • Aim: Diagnosis
Last updated Jun 27, 2026 11:01 UTC